364 related articles for article (PubMed ID: 31782885)
1. UHRF1 downmodulation enhances antitumor effects of histone deacetylase inhibitors in retinoblastoma by augmenting oxidative stress-mediated apoptosis.
Kim JK; Kan G; Mao Y; Wu Z; Tan X; He H; Lee C
Mol Oncol; 2020 Feb; 14(2):329-346. PubMed ID: 31782885
[TBL] [Abstract][Full Text] [Related]
2. UHRF1 depletion sensitizes retinoblastoma cells to chemotherapeutic drugs via downregulation of XRCC4.
He H; Lee C; Kim JK
Cell Death Dis; 2018 Feb; 9(2):164. PubMed ID: 29415984
[TBL] [Abstract][Full Text] [Related]
3. Silencing UHRF1 Inhibits Cell Proliferation and Promotes Cell Apoptosis in Retinoblastoma Via the PI3K/Akt Signalling Pathway.
Liu Y; Liang G; Zhou T; Liu Z
Pathol Oncol Res; 2020 Apr; 26(2):1079-1088. PubMed ID: 31044388
[TBL] [Abstract][Full Text] [Related]
4. Chromatin remodelers HELLS and UHRF1 mediate the epigenetic deregulation of genes that drive retinoblastoma tumor progression.
Benavente CA; Finkelstein D; Johnson DA; Marine JC; Ashery-Padan R; Dyer MA
Oncotarget; 2014 Oct; 5(20):9594-608. PubMed ID: 25338120
[TBL] [Abstract][Full Text] [Related]
5. UHRF1 depletion and HDAC inhibition reactivate epigenetically silenced genes in colorectal cancer cells.
Niinuma T; Kitajima H; Kai M; Yamamoto E; Yorozu A; Ishiguro K; Sasaki H; Sudo G; Toyota M; Hatahira T; Maruyama R; Tokino T; Nakase H; Sugai T; Suzuki H
Clin Epigenetics; 2019 May; 11(1):70. PubMed ID: 31064417
[TBL] [Abstract][Full Text] [Related]
6. Chromatin regulators in retinoblastoma: Biological roles and therapeutic applications.
Lee C; Kim JK
J Cell Physiol; 2021 Apr; 236(4):2318-2332. PubMed ID: 32840881
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the in vitro and in vivo antitumor activity of histone deacetylase inhibitors for the therapy of retinoblastoma.
Dalgard CL; Van Quill KR; O'Brien JM
Clin Cancer Res; 2008 May; 14(10):3113-23. PubMed ID: 18483379
[TBL] [Abstract][Full Text] [Related]
8. Negative regulation of the acetyltransferase TIP60-p53 interplay by UHRF1 (ubiquitin-like with PHD and RING finger domains 1).
Dai C; Shi D; Gu W
J Biol Chem; 2013 Jul; 288(27):19581-92. PubMed ID: 23677994
[TBL] [Abstract][Full Text] [Related]
9. The vicious circle of UHRF1 down-regulation and KEAP1/NRF2/HO-1 pathway impairment promotes oxidative stress-induced endothelial cell apoptosis in diabetes.
Guo Z; Wan X; Luo Y; Liang F; Jiang S; Yuan X; Mo Z
Diabet Med; 2023 Apr; 40(4):e15026. PubMed ID: 36510823
[TBL] [Abstract][Full Text] [Related]
10. UHRF1 Induces Methylation of the
Kim MJ; Lee HJ; Choi MY; Kang SS; Kim YS; Shin JK; Choi WS
Mol Cells; 2021 Mar; 44(3):146-159. PubMed ID: 33795533
[TBL] [Abstract][Full Text] [Related]
11. UHRF1 promotes proliferation of gastric cancer via mediating tumor suppressor gene hypermethylation.
Zhou L; Shang Y; Jin Z; Zhang W; Lv C; Zhao X; Liu Y; Li N; Liang J
Cancer Biol Ther; 2015; 16(8):1241-51. PubMed ID: 26147747
[TBL] [Abstract][Full Text] [Related]
12. Triggering p53 activation is essential in ziyuglycoside I-induced human retinoblastoma WERI-Rb-1 cell apoptosis.
Zhu X; Wang K; Yao Y; Zhang K; Zhou F; Zhu L
J Biochem Mol Toxicol; 2018 Jan; 32(1):. PubMed ID: 28960612
[TBL] [Abstract][Full Text] [Related]
13. L1 increases adhesion-mediated proliferation and chemoresistance of retinoblastoma.
Jo DH; Lee K; Kim JH; Jun HO; Kim Y; Cho YL; Yu YS; Min JK; Kim JH
Oncotarget; 2017 Feb; 8(9):15441-15452. PubMed ID: 28061460
[TBL] [Abstract][Full Text] [Related]
14. UHRF1 is associated with epigenetic silencing of BRCA1 in sporadic breast cancer.
Jin W; Chen L; Chen Y; Xu SG; Di GH; Yin WJ; Wu J; Shao ZM
Breast Cancer Res Treat; 2010 Sep; 123(2):359-73. PubMed ID: 19943104
[TBL] [Abstract][Full Text] [Related]
15. Mitochondrial apoptosis and FAK signaling disruption by a novel histone deacetylase inhibitor, HTPB, in antitumor and antimetastatic mouse models.
Shieh JM; Wei TT; Tang YA; Huang SM; Wen WL; Chen MY; Cheng HC; Salunke SB; Chen CS; Lin P; Chen CT; Wang YC
PLoS One; 2012; 7(1):e30240. PubMed ID: 22279574
[TBL] [Abstract][Full Text] [Related]
16. PARP inhibitor veliparib and HDAC inhibitor SAHA synergistically co-target the UHRF1/BRCA1 DNA damage repair complex in prostate cancer cells.
Yin L; Liu Y; Peng Y; Peng Y; Yu X; Gao Y; Yuan B; Zhu Q; Cao T; He L; Gong Z; Sun L; Fan X; Li X
J Exp Clin Cancer Res; 2018 Jul; 37(1):153. PubMed ID: 30012171
[TBL] [Abstract][Full Text] [Related]
17. UHRF1 depletion causes a G2/M arrest, activation of DNA damage response and apoptosis.
Tien AL; Senbanerjee S; Kulkarni A; Mudbhary R; Goudreau B; Ganesan S; Sadler KC; Ukomadu C
Biochem J; 2011 Apr; 435(1):175-85. PubMed ID: 21214517
[TBL] [Abstract][Full Text] [Related]
18. Targeting of histone methyltransferase DOT1L plays a dual role in chemosensitization of retinoblastoma cells and enhances the efficacy of chemotherapy.
Mao Y; Sun Y; Wu Z; Zheng J; Zhang J; Zeng J; Lee C; Kim JK
Cell Death Dis; 2021 Dec; 12(12):1141. PubMed ID: 34887387
[TBL] [Abstract][Full Text] [Related]
19. microRNA-222-Mediated VHL Downregulation Facilitates Retinoblastoma Chemoresistance by Increasing HIF1α Expression.
Li C; Zhao J; Sun W
Invest Ophthalmol Vis Sci; 2020 Aug; 61(10):9. PubMed ID: 32756923
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the therapeutic effects of lobaplatin and carboplatin on retinoblastoma in vitro and in vivo.
Zhou Z; Jiang H; Xia J; Zhang J
Int J Oncol; 2020 Sep; 57(3):697-706. PubMed ID: 32582992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
